Collegium Pharmaceutical Target Price

Collegium Pharmaceutical target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$25.7

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-02-10	Truist FinancialLes Sulewski	$58	125.7% upside
2026-01-09	Barclays	$56	117.9% upside
2026-01-09	H.C. Wainwright	$60	133.5% upside
2026-01-07	Truist Financial	$55	114% upside
2025-12-08	Barclays	$58	125.7% upside
2025-02-04	Piper SandlerDavid Amsellem	$36	40.1% upside
2024-11-11	JefferiesGlen Santangelo	$40	55.6% upside
2024-09-04	H.C. WainwrightOren Livnat	$50	94.6% upside
2024-08-09	Piper SandlerDavid Amsellem	$37	44% upside
2024-07-30	H.C. WainwrightOren Livnat	$47	82.9% upside
2024-06-07	JefferiesGlen Santangelo	$44	71.2% upside
2024-05-10	Piper SandlerDavid Amsellem	$39	51.8% upside
2023-01-05	Needham	$35	36.2% upside

Collegium Pharmaceutical (COLL) FAQ

Stockcircle tracks target price for Collegium Pharmaceutical (COLL), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Collegium Pharmaceutical's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main COLL overview so you can move from this figure to the surrounding analysis quickly.